Using a high-quality insulin syringe with a thin 30G needle (such as the BD MICRO-FINE+ Insulin Syringe) makes injection practically painless
Contraindication Signals Standard conservative practice excludes anyone with active gastrointestinal disease, type 1 diabetes, prior pancreatitis, medullary thyroid carcinoma history, or active cancer from any retatrutide protocol
Frequently Asked Questions Is Retatrutide FDA-approved
Tirzepatide makes you eat less and improves how your body handles the food you do eat
The combination of healthy fats with protein and fiber creates a synergistic effect on GLP-1 secretion that no single supplement ingredient can match
Currently available only within Phase 3 clinical trials, retatrutide simultaneously activates GLP-1, GIP, and glucagon receptors, distinguishing it from approved therapies such as semaglutide and tirzepatide